| abstract |
The application is directed to a composition and its use for treating inflammation comprising a non-steroidal anti-inflammatory active agent, a metasilicate, a first disintegrant and a second disintegrant, resulting in increased absorption of said active in mammals with suppressed vagal systems The preferred composition includes a non-steroidal anti-inflammatory active, sodium bicarbonate, tartaric acid and metasilicate. |